People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

30 Sep 2020
Change (% chg)

$0.03 (+0.78%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Alva, Emily 

Ms. Emily Peterson Alva serves as Independent Director of the Company. Ms. Alva is a financial, strategic and business advisor to senior executives, founders and corporate boards of directors, and has focused on private company advisory projects and family office investing since 2013. Prior to that time, Ms. Alva spent more than 15 years at Lazard as a senior mergers & acquisitions investment banker advising industry leading companies. Ms. Alva’s extensive advisory and transaction work covers multiple industries with a primary sector focus and expertise in healthcare. While at Lazard, Ms. Alva held leadership roles, both with clients and internally. She advised some of Lazard’s most important clients over many years, and was one of the youngest bankers promoted to Managing Director at the firm. During her Lazard tenure, Ms. Alva was selected for the Council on Foreign Relations’ Corporate Leaders Program, which recognizes accomplished professionals on a senior management track and links business leaders with decision makers in government and academia. Prior to joining Lazard, Ms. Alva worked at a development stage company focused on engineering-based solutions to improve industrial waste processing systems. More recently, Ms. Alva has served as a Board Member and Treasurer for the Alumnae Board of Directors of Barnard College. Ms. Alva received a BA in Economics from Barnard College, Columbia University

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 90,749
Long-Term Incentive Plans, USD --
All Other, USD 268,094
Fiscal Year Total, USD 358,843

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --